Company: OPGN
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001829126-25-009312
Chunk: 2

Company: OPGEN INC
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
502

    Change in inventory reserve

    -

    (54,830
    )
  
    Stock compensation expense

    284,208

    558,158

    Loss on deconsolidation of subsidiaries

    -

    75,138

    Change in fair value of EIB loan guaranty

    -

    (10,873,867
    )
  
    Gain on impairment adjustment

    -

    (2,079,575
    )
  
    Gain on settlement of compensation expenses

    -

    (570,785
    )
  
    Changes in operating assets and liabilities:

    Accounts receivable

    (4,014,580
    )

    78,915

    Inventory

    -

    54,830

    Prepaid expenses and other current assets

    244,269

    104,502

    Deferred offering costs

    6,269

    (6,269
    )
  
    Intangible assets

    (50,000
    )

    -

    Accounts payable

    62,580

    (7,281
    )
  
    Accrued compensation and benefits

    (37,463
    )

    (78,455
    )
  
    Accrued liabilities

    19,681

    524,483

    Operating lease liabilities

    (127,821
    )

    (108,744
    )
  
    Deferred revenue

    -

    (25,926
    )
  
    Net cash used in operating activities

    (978,685
    )

    (4,637,508
    )

    Cash flows from investing activities:

    Net cash used in investing activities

    -

    -

    Cash flows from financing activities:

    Proceeds from issuance of preferred stock, net of issuance costs

    -

    2,950,217

    Proceeds from issuance of common stock, net of issuance costs

    1,988,359

    Proceeds from short term insurance financing

    284,304

    300,926

    Payments on short term insurance financing

    (202,061
    )

    (120,371
    )
  
    Payments on finance lease obligations

    -

    (280
    )
  
    Net cash provided by financing activities

    82,243

    5,118,851

    Effects of exchange rates on cash

    -

    -

    Net (decrease